SCHEMBL29081431

SCHEMBL29081431

CC1CCC(c2ccc3sc(C(C)(C)N(C)C)nc3c2)=NC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29347517 1.00 — —
SCHEMBL30469984 1.00 — —
SCHEMBL29335687 0.86 PDE3B (0.34) —
SCHEMBL29082045 0.84 — —
SCHEMBL24367507 0.83 — —
SCHEMBL30470972 0.83 — —
SCHEMBL32688952 0.83 — —
SCHEMBL25321474 0.81 — —
SCHEMBL25322588 0.81 — —
SCHEMBL30514972 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116568677-A piperidin-1-yl-N-pyridin-3-yl-2-oxoacetamide derivatives useful for the treatment of MTAP deficiency and/or MTA accumulating cancers 探戈医药股份有限公司 2023-08-08 — — CN disclosed
Send feedback